Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030

Roots Analysis is pleased to announce the publication of its recent study, titled, "Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030."
 
 
Spread the Word
Listed Under

Tag:
* Biotech

Industry:
* Research

Location:
* Beaumont - California - US

Subject:
* Reports

BEAUMONT, Calif. - July 16, 2020 - PRLog -- The report features an extensive study of the current market landscape and future opportunities associated with cell therapy manufacturing. It focuses on both contract manufacturers, as well as developers with in-house manufacturing facilities, offering in-depth analyses of the various business entities that are engaged in this domain, across different global regions. Amongst other elements, the report includes:

§  An analysis of the various expansion initiatives undertaken by service providers, in order to augment their respective cell therapy manufacturing capabilities, over the period 2015-2019.

§  An analysis of the recent partnerships focused on the manufacturing of cell-based therapies, which have been established in the period 2014-2019.

§  Informed estimates of the annual commercial and clinical demand for cell therapies, in terms of number of cells produced and area dedicated to manufacturing.

§  An estimate of the overall, installed capacity for manufacturing cell-based therapies based on information reported by industry stakeholders in the public domain A competitiveness analysis of biological targets, featuring insightful pictorial summaries and representations.

§  A detailed analysis of the various factors that are likely to influence the pricing of cell-based therapies, featuring different models / approaches that may be adopted by manufacturers while deciding the prices of their proprietary offerings.

§  A qualitative analysis, highlighting the various factors that need to be taken into consideration by cell therapy developers while deciding whether to manufacture their respective products in-house or engage the services of a CMO.

§  An elaborate discussion on the role of automation technologies in improving current manufacturing methods.

§  A discussion on cell therapy manufacturing regulations across various geographies, including North America, Europe, and Asia Pacific.

§  Elaborate profiles of key players (industry and non-industry) that offer contract manufacturing services.

§  A discussion on affiliated trends, key drivers and challenges, which are likely to impact the industry's evolution, under a comprehensive SWOT framework.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

§  Type of therapy

§  T-cell therapies (CAR-T therapies, TCR therapies, TIL therapies)

§  Dendritic cell therapies

§  Tumor cell therapies

§  NK cell therapies

§  Stem cell therapies

§  Source of cells

§  Autologous

§  Allogeneic

§  Scale of operation

§  Clinical

§  Commercial

§  Purpose of manufacturing

§  Contract manufacturing

For additional details, please visit

https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html or email sales@rootsanalysis.com


Contact:

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

https://www.rootsanalysis.com/

Contact
Roots Analysis
***@gmail.com
End
Email:***@gmail.com
Tags:Biotech
Industry:Research
Location:Beaumont - California - United States
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Roots Analysis News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share